Vabrinty 85043-0045-04

Generic: Leuprolide Acetate

Package NDC

85043-0045-04

Manufacturer: Uronova Pharmaceuticals, Inc.
Dosage Form: Injection, Suspension, Extended Release
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: August 4, 2025
Listing Expires: December 31, 2027
Application: NDA021731

Need to source Vabrinty? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Leuprolide Acetate	45 mg/.375mL

Drug Class

Gonadotropin Releasing Hormone Receptor Agonist [EPC]Gonadotropin Releasing Hormone Receptor Agonists [MoA]

Selected Package

85043-0045-04Selected

1 SYRINGE in 1 CARTON (85043-045-04) / .375 mL in 1 SYRINGE